Intravenous aflibercept administered in combination with irinotecan, 5-fluorouracil and leucovorin in patients with advanced solid tumours: results from the expansion cohort of a phase I study. (Q45936799)
Jump to navigation
Jump to search
scientific article published on 10 January 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intravenous aflibercept administered in combination with irinotecan, 5-fluorouracil and leucovorin in patients with advanced solid tumours: results from the expansion cohort of a phase I study. |
scientific article published on 10 January 2013 |
Statements
1 reference
Intravenous aflibercept administered in combination with irinotecan, 5-fluorouracil and leucovorin in patients with advanced solid tumours: results from the expansion cohort of a phase I study. (English)
1 reference
David Khayat
1 reference
Sabine Tejpar
1 reference
Jean-Philippe Spano
1 reference
Chris Verslype
1 reference
Joël Bloch
1 reference
Vincent Vandecaveye
1 reference
Sylvie Assadourian
1 reference
Karen Soussan-Lazard
1 reference
Sylvaine Cartot-Coton
1 reference
Eric Van Cutsem
1 reference
10 January 2013
1 reference
1 reference
49
1 reference
4
1 reference
790-797
1 reference
Identifiers
1 reference
1 reference